These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19428771)

  • 1. Nociceptin-induced modulation of human T cell function.
    Easten KH; Harry RA; Purcell WM; McLeod JD
    Peptides; 2009 May; 30(5):926-34. PubMed ID: 19428771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ modulates human T cell function in vitro.
    Waits PS; Purcell WM; Fulford AJ; McLeod JD
    J Neuroimmunol; 2004 Apr; 149(1-2):110-20. PubMed ID: 15020071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
    Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
    Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
    Arduin M; Spagnolo B; Calò G; Guerrini R; Carrà G; Fischetti C; Trapella C; Marzola E; McDonald J; Lambert DG; Regoli D; Salvadori S
    Bioorg Med Chem; 2007 Jul; 15(13):4434-43. PubMed ID: 17490886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ (N/OFQ) inhibits excitatory and inhibitory synaptic signaling in the suprachiasmatic nucleus (SCN).
    Gompf HS; Moldavan MG; Irwin RP; Allen CN
    Neuroscience; 2005; 132(4):955-65. PubMed ID: 15857701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
    Ozsoy HZ; Thakker DR; Standifer KM
    Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.
    Zhang C; McDougall JJ
    Br J Pharmacol; 2006 Aug; 148(7):938-46. PubMed ID: 16783411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
    Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
    J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats.
    Uchiyama H; Toda A; Hiranita T; Watanabe S; Eyanagi R
    Neurosci Lett; 2008 Jan; 431(1):66-70. PubMed ID: 18166271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.
    Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H
    J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the GABA/benzodiazepine receptor in the axiolytic-like effect of nociceptin/orphanin FQ.
    Uchiyama H; Yamaguchi T; Toda A; Hiranita T; Watanabe S; Eyanagi R
    Eur J Pharmacol; 2008 Aug; 590(1-3):185-9. PubMed ID: 18586237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel.
    Jia Y; Wang X; Aponte SI; Rivelli MA; Yang R; Rizzo CA; Corboz MR; Priestley T; Hey JA
    Br J Pharmacol; 2002 Feb; 135(3):764-70. PubMed ID: 11834624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of involvement of dopamine and serotonin during the orphanin FQ/Nociceptin (OFQ/N)-induced prolactin secretory response.
    Kraska A; Bryant W; Murphree E; Callahan P; Janik J
    Life Sci; 2005 Aug; 77(13):1465-79. PubMed ID: 15996688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell proliferation is inhibited by the induction of indoleamine 2,3-dioxygenase in spleen-derived dendritic cells in rat.
    Xu J; Yao N; Li YD
    Chin Med J (Engl); 2011 Oct; 124(19):3154-8. PubMed ID: 22040571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release.
    Gupta DS; Kelson AB; Polgar WE; Toll L; Szücs M; Gintzler AR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1213-20. PubMed ID: 11504823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
    Rossi GC; Leventhal L; Bolan E; Pasternak GW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apoptosis of K562 cells induced by nociceptin/orphanin FQ].
    Guo H; Zhao L; Zhang BH; Li J; Chen X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1116-9. PubMed ID: 17204175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.
    Ciccocioppo R; Cippitelli A; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2004 Aug; 82(1):63-8. PubMed ID: 15234592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.